Both in Pharmaceuticals
Prelude Therapeutics Incorporated vs ARS Pharmaceuticals
Over the past year PRLD returned +131.8% and SPRY returned −65.0%; their daily moves had a correlation of 0.14.
PRLD +131.8% SPRY −65.0%Growth of $1, one year, split-adjusted
| Metric | PRLD | SPRY |
|---|---|---|
| Price | $4.08 | $3.05 |
| Market cap | $325.6M | $303.3M |
| Today | +7.94% | 0.00% |
| 1 month | +7.1% | −29.0% |
| 6 months | −15.7% | −67.1% |
| Year to date | +40.7% | −73.8% |
| 1 year | +2.5% | −64.6% |
| Revenue growth (YoY) | — | +114.2% |
| Gross margin | 100.0% | 61.8% |
| Net margin | −244.1% | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | 14.5× | 2.6× |
| Net cash | $151.8M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 73.7% | 69.9% |
| Short % of float | 13.2% | 40.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).